BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10849891)

  • 21. Administration of donepezil does not rescue galanin-induced spatial learning deficits.
    Sabbagh JJ; Heaney CF; Bolton MM; Murtishaw AS; Ure JA; Kinney JW
    Int J Neurosci; 2012 Dec; 122(12):742-7. PubMed ID: 22897394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of novel 7-MEOTA-donepezil like hybrids and N-alkylated tacrine analogues in the treatment of quinuclidinyl benzilate-induced behavioural deficits in rats performing the multiple T-maze test.
    Misik J; Korabecny J; Nepovimova E; Cabelova P; Kassa J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):547-53. PubMed ID: 25690521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia.
    Dimitrova DS; Getova-Spassova DP
    J Pharmacol Sci; 2006 Jul; 101(3):199-204. PubMed ID: 16861821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donepezil induces a cholinergic sprouting in basocortical degeneration.
    Ginestet L; Ferrario JE; Raisman-Vozari R; Hirsch EC; Debeir T
    J Neurochem; 2007 Jul; 102(2):434-40. PubMed ID: 17394553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.
    Chen H; Xiang S; Huang L; Lin J; Hu S; Mak SH; Wang C; Wang Q; Cui W; Han Y
    Metab Brain Dis; 2018 Aug; 33(4):1131-1139. PubMed ID: 29564727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats.
    Gawel K; Labuz K; Gibula-Bruzda E; Jenda M; Marszalek-Grabska M; Filarowska J; Silberring J; Kotlinska JH
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1059-71. PubMed ID: 27376896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosmarinic acid protects against chronic ethanol-induced learning and memory deficits in rats.
    Hasanein P; Seifi R; Hajinezhad MR; Emamjomeh A
    Nutr Neurosci; 2017 Nov; 20(9):547-554. PubMed ID: 27367870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 1999 Sep; 380(2-3):101-7. PubMed ID: 10513568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping.
    Lindner MD; Hogan JB; Hodges DB; Orie AF; Chen P; Corsa JA; Leet JE; Gillman KW; Rose GM; Jones KM; Gribkoff VK
    Psychopharmacology (Berl); 2006 Nov; 188(4):629-40. PubMed ID: 17004085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of scopolamine-induced spatial and recognition memory deficits in mice by novel multifunctional dimers bis-cognitins.
    Han RW; Zhang RS; Chang M; Peng YL; Wang P; Hu SQ; Choi CL; Yin M; Wang R; Han YF
    Brain Res; 2012 Aug; 1470():59-68. PubMed ID: 22750583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats.
    Pattanashetti LA; Taranalli AD; Parvatrao V; Malabade RH; Kumar D
    Indian J Pharmacol; 2017; 49(1):60-64. PubMed ID: 28458424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A benzothiazole/piperazine derivative with acetylcholinesterase inhibitory activity: Improvement in streptozotocin-induced cognitive deficits in rats.
    Demir Özkay Ü; Can ÖD; Sağlık BN; Turan N
    Pharmacol Rep; 2017 Dec; 69(6):1349-1356. PubMed ID: 29132093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents.
    Chopin P; Colpaert FC; Marien M
    J Pharmacol Exp Ther; 2002 Apr; 301(1):187-96. PubMed ID: 11907173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults.
    Thomas E; Snyder PJ; Pietrzak RH; Jackson CE; Bednar M; Maruff P
    Neuropsychologia; 2008 Aug; 46(10):2476-84. PubMed ID: 18514746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
    Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.
    Cheng DH; Tang XC
    Pharmacol Biochem Behav; 1998 Jun; 60(2):377-86. PubMed ID: 9632220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of neuroprotection of donepezil, a therapy for Alzheimer's disease.
    Akasofu S; Kimura M; Kosasa T; Sawada K; Ogura H
    Chem Biol Interact; 2008 Sep; 175(1-3):222-6. PubMed ID: 18571635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
    Smith CP; Bores GM; Petko W; Li M; Selk DE; Rush DK; Camacho F; Winslow JT; Fishkin R; Cunningham DM; Brooks KM; Roehr J; Hartman HB; Davis L; Vargas HM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):710-20. PubMed ID: 9023283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease.
    Liston DR; Nielsen JA; Villalobos A; Chapin D; Jones SB; Hubbard ST; Shalaby IA; Ramirez A; Nason D; White WF
    Eur J Pharmacol; 2004 Feb; 486(1):9-17. PubMed ID: 14751402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.